6.6M
XNAS Volume
High volume+loss today
XNAS 18 Mar, 2025 4:00 PM (EDT)
Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|
Thomas E. Price | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 482,640 | 482,640 | - | - | Stock Option (Right to Buy) | |
Lawrence B. Leisure | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 482,640 | 482,640 | - | - | Stock Option (Right to Buy) | |
Gregory N. Kazarian | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 482,640 | 482,640 | - | - | Stock Option (Right to Buy) | |
Mary A. Tolan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 482,640 | 482,640 | - | - | Stock Option (Right to Buy) | |
Mark A. Thierer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 965,279 | 965,279 | - | - | Stock Option (Right to Buy) | |
Gregory D. Wasson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 482,640 | 482,640 | - | - | Stock Option (Right to Buy) | |
Aric Coffman | See remarks. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2024 | 12,100,000 | 12,100,000 | - | - | Stock Option (Right to Buy) | |
Abdou Sherif | Director, Chief Executive Officer, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 09 Jan 2024 | 483,868 | 1,608,225 | - | - | Class A Common Stock | |
Amir Bacchus | Director, Chief Medical Officer | Other type of transaction at price $ 0.00 per share. | 09 Jan 2024 | 287,118 | 2,005,193 | - | - | Class A Common Stock | |
Amir Bacchus | Director, Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.41 per share. | 31 Dec 2023 | 287,118 | 1,718,075 | - | 1.4 | 404,836 | Class A Common Stock |
Abdou Sherif | Director, Chief Executive Officer, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.41 per share. | 31 Dec 2023 | 483,868 | 1,124,357 | - | 1.4 | 682,254 | Class A Common Stock |
Leisure B. Lawrence | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Oct 2023 | 216,561 | 216,561 | - | 0 | Class A Common Stock | |
Thierer A. Mark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Oct 2023 | 433,121 | 433,121 | - | 0 | Class A Common Stock | |
E. Thomas Price | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Oct 2023 | 216,561 | 216,561 | - | 0 | Class A Common Stock | |
Kazarian Gregory N. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Oct 2023 | 216,561 | 216,561 | - | 0 | Class A Common Stock | |
A. Tolan Mary | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Oct 2023 | 216,561 | 216,561 | - | 0 | Class A Common Stock | |
Wasson D. Gregory | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Oct 2023 | 216,561 | 216,561 | - | 0 | Class A Common Stock | |
Amir Bacchus | Director, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Aug 2023 | 1,000,000 | 2,005,193 | - | 0 | Class A Common Stock | |
Sherif Abdou | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Aug 2023 | 1,500,000 | 1,608,225 | - | 0 | Class A Common Stock | |
Atul Kavthekar | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Aug 2023 | 750,000 | 768,868 | - | 0 | Class A Common Stock | |
Atul Kavthekar | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 2.65 per share. | 15 May 2023 | 18,868 | 18,868 | - | 2.6 | 49,998 | Class A Common Stock |
Sherif Abdou | Director, Chief Executive Officer, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 2.63 per share. | 12 May 2023 | 108,225 | 108,225 | - | 2.6 | 284,448 | Class A Common Stock |
Amir Bacchus | Director, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Apr 2023 | 251,298 | 251,298 | - | - | Class A Common Stock | |
Amir Bacchus | Director, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Apr 2023 | 188,474 | 188,474 | - | - | Warrant | |
Amir Bacchus | Director, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Apr 2023 | 1,005,193 | 1,005,193 | - | - | Class A Common Stock | |
Amir Bacchus | Director, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Apr 2023 | 753,895 | 753,895 | - | - | Warrant | |
Erin Darakjian | Interim CFO, Senior VP & CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Nov 2022 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
Gregory N. Kazarian | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Mar 2022 | 85,535 | 85,535 | - | - | Stock Option (Right to Buy) | |
Thomas E. Price | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Mar 2022 | 85,535 | 85,535 | - | - | Stock Option (Right to Buy) | |
Lawrence B. Leisure | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Mar 2022 | 85,535 | 85,535 | - | - | Stock Option (Right to Buy) | |
Mary A. Tolan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Mar 2022 | 85,535 | 85,535 | - | - | Stock Option (Right to Buy) | |
Mark A. Thierer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Mar 2022 | 171,069 | 171,069 | - | - | Stock Option (Right to Buy) | |
Mark A. Thierer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Mar 2022 | 200,000 | 200,000 | - | - | Stock Option (Right to Buy) | |
Gregory D. Wasson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Mar 2022 | 85,535 | 85,535 | - | - | Stock Option (Right to Buy) | |
Gregory N. Kazarian | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Dec 2021 | 471,064 | 471,064 | - | - | Common Units | |
Gregory N. Kazarian | Director | Grant, award, or other acquisition of securities at price $ 70.66 per share. | 03 Dec 2021 | 706,595 | 706,595 | - | 70.7 | 49,928,003 | Class V Common Stock |
Gregory N. Kazarian | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Dec 2021 | 706,595 | 706,595 | - | - | Common Units | |
Gregory N. Kazarian | Director | Grant, award, or other acquisition of securities at price $ 47.11 per share. | 03 Dec 2021 | 471,064 | 471,064 | - | 47.1 | 22,191,825 | Class V Common Stock |
Sherif Abdou | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 305.85 per share. | 03 Dec 2021 | 3,058,479 | 3,058,479 | - | 305.8 | 935,435,802 | Class V Common Stock |
Sherif Abdou | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 962.61 per share. | 03 Dec 2021 | 9,626,075 | 9,626,075 | - | 962.6 | 9,266,156,056 | Class V Common Stock |
Sherif Abdou | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 140.84 per share. | 03 Dec 2021 | 1,408,437 | 1,408,437 | - | 140.8 | 198,364,267 | Class V Common Stock |
Sherif Abdou | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Dec 2021 | 9,626,075 | 9,626,075 | - | - | Common Units | |
Sherif Abdou | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Dec 2021 | 3,058,479 | 3,058,479 | - | - | Common Units | |
Sherif Abdou | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Dec 2021 | 1,408,437 | 1,408,437 | - | - | Common Units | |
Sherif Abdou | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Dec 2021 | 9,626,075 | 9,626,075 | - | - | Common Units | |
Sherif Abdou | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Dec 2021 | 3,058,479 | 3,058,479 | - | - | Common Units | |
Sherif Abdou | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Dec 2021 | 1,408,437 | 1,408,437 | - | - | Common Units | |
Sherif Abdou | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 962.61 per share. | 03 Dec 2021 | 9,626,075 | 9,626,075 | - | 962.6 | 9,266,156,056 | Class V Common Stock |
Sherif Abdou | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 305.85 per share. | 03 Dec 2021 | 3,058,479 | 3,058,479 | - | 305.8 | 935,435,802 | Class V Common Stock |
Sherif Abdou | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 140.84 per share. | 03 Dec 2021 | 1,408,437 | 1,408,437 | - | 140.8 | 198,364,267 | Class V Common Stock |
Amir Bacchus | Director, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 375.81 per share. | 03 Dec 2021 | 3,758,130 | 3,758,130 | - | 375.8 | 1,412,342,835 | Class V Common Stock |
Amir Bacchus | Director, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 1503.25 per share. | 03 Dec 2021 | 15,032,528 | 15,032,528 | - | 1503.3 | 22,597,647,716 | Class V Common Stock |
Amir Bacchus | Director, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Dec 2021 | 3,758,130 | 3,758,130 | - | - | Common Units | |
Amir Bacchus | Director, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Dec 2021 | 15,032,528 | 15,032,528 | - | - | Common Units | |
Eric Atkins | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 45.05 per share. | 03 Dec 2021 | 450,517 | 450,517 | - | 45.1 | 20,295,791 | Class V Common Stock |
Eric Atkins | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Dec 2021 | 450,517 | 450,517 | - | - | Common Units | |
Thomas E. Price | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Dec 2021 | 1,177,659 | 1,177,659 | - | - | Common Units | |
Thomas E. Price | Director | Grant, award, or other acquisition of securities at price $ 117.77 per share. | 03 Dec 2021 | 1,177,659 | 1,177,659 | - | 117.8 | 138,692,900 | Class V Common Stock |